Caitong International Asset Management’s Definium Therapeutics DFTX Stock Holding History

Caitong International Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Sell	2,201 -1,835	-45%	-$45.3K	0.01%	549
2026 Q1	$76.3K	Buy	4,036 +4,021	+26,807%	+$68.2K	0.01%	660
2025 Q4	$201	Buy	+15	New	+$186	﹤0.01%	1620
2025 Q3	–	Sell	-341	Closed	-$2.21K	–	2293
2025 Q2	$2.21K	Sell	341 -218	-39%	-$1.43K	﹤0.01%	1350
2025 Q1	$3.27K	Buy	+559	New	+$4K	﹤0.01%	1152

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Caitong International Asset Management's DFTX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Definium Therapeutics (DFTX) stake by 45% in Q2 2026, selling an estimated $45.3K and leaving 2,201 shares worth $104K. The position accounts for 0.01% of the portfolio, ranked #549.

Caitong International Asset Management first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Caitong International Asset Management held 2,201 shares of Definium Therapeutics worth $104K as of Q2 2026.
Caitong International Asset Management sold 1,835 Definium Therapeutics shares in Q2 2026, an estimated $45.3K.
Definium Therapeutics made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #549 holding.
Caitong International Asset Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.